20 results
424B3
PRTG
Portage Biotech Inc
28 Feb 24
Prospectus supplement
5:19pm
in a liposome with a six-member carbon head structure that has been shown to activate both human and murine iNKT cells, resulting in DC maturation
6-K
EX-99.2
PRTG
Portage Biotech Inc
28 Feb 24
Current report (foreign)
5:17pm
.
PORT-2 (IMM60)
PORT-2 is an iNKT cell engager formulated in a liposome with a six-member carbon head structure that has been shown to activate both
424B3
PRTG
Portage Biotech Inc
28 Nov 23
Prospectus supplement
4:03pm
intellectual property and know-how.
PORT-2 (IMM60)
PORT-2 is an iNKT cell engager formulated in a liposome with a six-member carbon head structure
6-K
EX-99.2
PRTG
Portage Biotech Inc
28 Nov 23
Current report (foreign)
4:01pm
cell engager formulated in a liposome with a six-member carbon head structure that has been shown to activate both human and murine iNKT cells
424B5
PRTG
Portage Biotech Inc
2 Oct 23
Prospectus supplement for primary offering
6:01pm
Institute's intellectual property and know-how.
PORT 2 (IMM60)
PORT-2 is an iNKT cell activator/agonist formulated in a liposome with a 6-member carbon
6-K
EX-99.2
6523j7de75sr 8yc
29 Aug 23
Current report (foreign)
4:01pm
6-K
EX-99.2
9cilv9tfzbjgpf8s
29 Nov 22
Current report (foreign)
4:58pm
6-K
EX-99.2
x1itszvouz3 jl3t88t1
29 Aug 22
Current report (foreign)
4:00pm
6-K
EX-99.2
js9wiu dfmy
25 Feb 22
Current report (foreign)
5:29pm
6-K
EX-99.2
72ses sdd
23 Nov 21
Current report (foreign)
4:30pm
6-K
EX-99.2
ksnvdzeu8bywvylytg
30 Aug 21
Current report (foreign)
5:21pm
SUPPL
rkm gxpcfdmkjlp8z
24 Jun 21
Supplemental materials (foreign)
5:27pm
SUPPL
cdsy1ezzfcjk
23 Jun 21
Supplemental materials (foreign)
4:01pm
424B2
l6kqrdw9q8c48t
8 Mar 21
Prospectus for primary offering
5:00pm
6-K
EX-99.2
5t1qf8043qj0t6 rbc3e
1 Mar 21
Condensed Consolidated Interim Financial Statements
4:23pm
F-3
qrxrrqvof zxgpkvdtfv
24 Feb 21
Shelf registration (foreign)
5:22pm
- Prev
- 1
- Next